122 related articles for article (PubMed ID: 37646142)
1. Bergenin Inhibits Tumor Growth and Overcomes Radioresistance by Targeting Aerobic Glycolysis.
Li X; Xie L; Zhou L; Gan Y; Han S; Zhou Y; Qing X; Li W
Am J Chin Med; 2023; 51(7):1905-1925. PubMed ID: 37646142
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
4. USP13 serves as a tumor suppressor via the PTEN/AKT pathway in oral squamous cell carcinoma.
Qu Z; Zhang R; Su M; Liu W
Cancer Manag Res; 2019; 11():9175-9183. PubMed ID: 31802942
[TBL] [Abstract][Full Text] [Related]
5. Bergenin inhibits bladder cancer progression via activating the PPARγ/PTEN/Akt signal pathway.
Liu J; Zhang Y; Yu C; Zhang P; Gu S; Wang G; Xiao H; Li S
Drug Dev Res; 2021 Apr; 82(2):278-286. PubMed ID: 33112006
[TBL] [Abstract][Full Text] [Related]
6. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
7. Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis.
Xie L; Liao J; Liu W; Wang R; Li X; Li W; Zhou Z
Cell Death Discov; 2023 Oct; 9(1):364. PubMed ID: 37779163
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
9. PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma.
Zhuo B; Li Y; Li Z; Qin H; Sun Q; Zhang F; Shen Y; Shi Y; Wang R
Biochem Biophys Res Commun; 2015 Aug; 464(2):401-6. PubMed ID: 26116768
[TBL] [Abstract][Full Text] [Related]
10. Survivin degradation by bergenin overcomes pemetrexed resistance.
Li X; Liang Q; Zhou L; Deng G; Xiao Y; Gan Y; Han S; Liao J; Wang R; Qing X; Li W
Cell Oncol (Dordr); 2023 Dec; 46(6):1837-1853. PubMed ID: 37542022
[TBL] [Abstract][Full Text] [Related]
11. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.
Pai S; Yadav VK; Kuo KT; Pikatan NW; Lin CS; Chien MH; Lee WH; Hsiao M; Chiu SC; Yeh CT; Tsai JT
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768921
[No Abstract] [Full Text] [Related]
12. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2.
Zheng Z; Ma X; Li H
J Cell Mol Med; 2020 Jul; 24(13):7531-7537. PubMed ID: 32410389
[TBL] [Abstract][Full Text] [Related]
14. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
[TBL] [Abstract][Full Text] [Related]
15. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
16. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
18. FoxA2 inhibits the proliferation of hepatic progenitor cells by reducing PI3K/Akt/HK2-mediated glycolysis.
Wang P; Cong M; Liu T; Li Y; Liu L; Sun S; Sun L; Zhu Z; Ma H; You H; Zhang H; Jia J
J Cell Physiol; 2020 Dec; 235(12):9524-9537. PubMed ID: 32495363
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway.
Wang Q; Lv L; Li Y; Ji H
Mol Med Rep; 2018 Sep; 18(3):3106-3114. PubMed ID: 30015840
[TBL] [Abstract][Full Text] [Related]
20. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]